论文部分内容阅读
目的:评价坦索罗辛对输尿管下段结石体外冲击波碎石(ESWL)术后患者辅助排石的临床疗效。方法:选取2012年12月—2014年12月收治的行输尿管下段结石行ESWL术患者128例为研究资料,将其随机分为对照组和观察组,每组64例;对照组患者均给予肾石通颗粒与山莨菪碱联用治疗,观察组患者均给予肾石通颗粒、山莨菪碱与坦索罗辛联用治疗;比较两组患者的排石率和排石时间。结果:观察组患者治疗后结石排除率、排净率与排出时间明显均优于对照组(P<0.05)。结论:坦索罗辛对输尿管下段结石ESWL术后辅助排石的临床疗效较好,可提高结石排除率和排净率,并缩短排石时间。
OBJECTIVE: To evaluate the clinical effect of tamsulosin on the auxiliary row of stone after ESWL in patients with lower ureteral calculi. Methods: A total of 128 ESWL patients undergoing ureteral calculi from December 2012 to December 2014 were selected as study data, which were randomly divided into control group and observation group with 64 cases in each group. Patients in control group were given kidney Shengtong particles combined with anisodamine treatment, the observation group were given kidney stone particles, anisodamine and tamsulosin combined treatment; compared the two groups of patients with stone discharge rate and row of stone time. Results: The stone removal rate, clearance rate and discharge time in the observation group were significantly better than those in the control group (P <0.05). CONCLUSION: Tamsulosin has a good clinical effect on ESWL after lower ureteral calculi, which can improve the rate of stone removal and rejection and shorten the time of stone removal.